649755-90-8 Usage
Uses
Used in Pharmaceutical Industry:
(R)-4-benzyl-3-[(Z)-(2R,3S,4R,5S,6S)-3-(tert-butyldimethylsilanyloxy)-2,4,6-trimethyl-5-triethylsilanyloxydeca-7,9-dienoyl]-oxazolidin-2-one is used as a potential pharmaceutical compound for its complex structure and chirality. (R)-4-benzyl-3-[(Z)-(2R,3S,4R,5S,6S)-3-(tert-butyldimethylsilanyloxy)-2,4,6-trimethyl-5-triethylsilanyloxydeca-7,9-dienoyl]-oxazolidin-2-one's unique features may allow it to interact with biological targets in novel ways, potentially leading to the development of new drugs.
Used in Chemical Industry:
In the chemical industry, (R)-4-benzyl-3-[(Z)-(2R,3S,4R,5S,6S)-3-(tert-butyldimethylsilanyloxy)-2,4,6-trimethyl-5-triethylsilanyloxydeca-7,9-dienoyl]-oxazolidin-2-one may be utilized as a building block or intermediate in the synthesis of other complex molecules. Its reactivity and structural diversity could be harnessed for creating new materials or chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 649755-90-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,9,7,5 and 5 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 649755-90:
(8*6)+(7*4)+(6*9)+(5*7)+(4*5)+(3*5)+(2*9)+(1*0)=218
218 % 10 = 8
So 649755-90-8 is a valid CAS Registry Number.
649755-90-8Relevant academic research and scientific papers
A formal synthesis of (+)-discodermolide
Loiseleur, Olivier,Koch, Guido,Cercus, Jacques,Schuerch, Friedrich
, p. 259 - 271 (2012/12/24)
Herein, we report the formal synthesis of (+)-discodermolide (1), a promising anticancer agent of sponge origin, in 24 linear steps, with 35 steps in total. The route proceeds from lactone 2, a building block containing the common 1,2-anti-2,3-syn stereot
SYNTHESIS OF DISCODERMOLIDE
-
Page 62, (2010/11/30)
The invention relates to a process for preparing discodermolide, for preparing intermediates for the manufacture of discodermolide and discodermolide analogues and to the intermediates obtained during the process. Wherein the process proceeds via a tetrae
